The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobilit… (NCT07073144) | Clinical Trial Compass
CompletedNot Applicable
The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility Impairment
Hong Kong24 participantsStarted 2025-05-09
Plain-language summary
This intervention aims to develop and test the feasibility, acceptability, and preliminary effects of a "Digital Strolling" intervention among people with SMI. The intervention group will receive a "Digital Strolling" intervention, which consists of 20 minutes "Digital strolling" for 10 days, with lessons occurring once a day. The control group will receive passive observation of virtual walking videos only.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Inability to walk 4 meters in less than 10 seconds without walking aids, or self-, proxy-, or medical-record-reported inability to walk independently across a small room (≈ 4 m), or dependence on a walking aid for more than 6 months
* Minimum 6 months post-injury or disease onset
* Able to communicate in Cantonese
Exclusion Criteria:
* Have severe cognitive impairment (a score \< 6 on the Abbreviated Mental Test)
* Have severe mental illness (i.e., schizophrenia and major depression)
* Have acute medical illness or exacerbation requiring hospital or intensive treatment; planned major surgery or inpatient rehabilitation during the study period
* Currently engage in similar interventions
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial has already completed — is there any published data or preliminary results available that you could review with me to understand whether digital strolling seemed to help people with conditions like mine?
2Since this was a feasibility study focused on things like recruitment and drop-out rates rather than proving the intervention works, what would that mean for how much confidence we can have in any benefits it showed?
3The trial included people with spinal cord injuries and poliomyelitis — given my specific diagnosis and level of mobility, do you think my situation is close enough to the participants studied for the findings to be relevant to me?
4The study tracked adverse events, so are there any safety concerns that came up during the trial that I should know about before considering something like virtual reality or digital walking as part of my care?
5Are there other established treatments for depression and quality of life in people with severe mobility impairment that I should try first, or could something like digital strolling work alongside what I'm already doing?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility: Time taken to recruit the sample
Timeframe: The outcome will be assessed through study completion, which is expected to be an average of 6 months.
2
Feasibility: Recruitment rate
Timeframe: The outcome will be assessed through study completion, which is expected to be an average of 6 months.
3
Feasibility: Drop-out rate
Timeframe: The outcome will be assessed through study completion, which is expected to be an average of 6 months.
4
Acceptability: Adherence rate
Timeframe: This outcome will be measured at the end of the 10-day intervention period.
5
Intervention satisfaction
Timeframe: The outcome will be assessed 1 week post-intervention.
6
Adverse event
Timeframe: The outcome will be assessed through study completion, which is expected to be an average of 6 months.